Singular Genomics Systems, Inc. (OMIC)
USD 20.01
(0.0%)
USD 20.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 86.46 Million USD | 27.8% |
| 2022 | 67.65 Million USD | 247.39% |
| 2021 | 19.47 Million USD | -76.27% |
| 2020 | 82.05 Million USD | 12.56% |
| 2019 | 72.89 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 82.4 Million USD | -4.69% |
| 2024 Q2 | 82.29 Million USD | -0.13% |
| 2023 FY | 86.46 Million USD | 27.8% |
| 2023 Q3 | 85.49 Million USD | 30.34% |
| 2023 Q2 | 65.59 Million USD | 0.69% |
| 2023 Q4 | 86.46 Million USD | 1.13% |
| 2023 Q1 | 65.14 Million USD | -3.71% |
| 2022 Q3 | 68.55 Million USD | -0.43% |
| 2022 Q1 | 24.62 Million USD | 26.46% |
| 2022 FY | 67.65 Million USD | 247.39% |
| 2022 Q4 | 67.65 Million USD | -1.31% |
| 2022 Q2 | 68.84 Million USD | 179.54% |
| 2021 Q4 | 19.47 Million USD | 3.79% |
| 2021 Q3 | 18.76 Million USD | 7.82% |
| 2021 Q2 | 17.4 Million USD | -92.4% |
| 2021 FY | 19.47 Million USD | -76.27% |
| 2021 Q1 | 228.96 Million USD | 179.03% |
| 2020 Q4 | 82.05 Million USD | 0.0% |
| 2020 FY | 82.05 Million USD | 12.56% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 72.89 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 31.705% |
| AngioDynamics, Inc. | 112.08 Million USD | 22.861% |
| AtriCure, Inc. | 147.76 Million USD | 41.487% |
| Avinger, Inc. | 19.97 Million USD | -332.911% |
| Azenta, Inc. | 351.22 Million USD | 75.383% |
| BioLife Solutions, Inc. | 75.05 Million USD | -15.203% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 97.895% |
| Daxor Corporation | 858.75 Thousand USD | -9968.145% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -430.045% |
| Femasys Inc. | 9.4 Million USD | -819.481% |
| GlucoTrack, Inc. | 1.7 Million USD | -4962.119% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -34.482% |
| Hologic, Inc. | 4.02 Billion USD | 97.852% |
| ICU Medical, Inc. | 2.25 Billion USD | 96.166% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 95.77% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -966.472% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -76.891% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -13001.422% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -13001.422% |
| Masimo Corporation | 1.67 Billion USD | 94.843% |
| Microbot Medical Inc. | 3.82 Million USD | -2159.827% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -244.776% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 92.303% |
| Nephros, Inc. | 3.5 Million USD | -2368.199% |
| NovoCure Limited | 783.63 Million USD | 88.967% |
| NEXGEL, Inc. | 4.78 Million USD | -1705.408% |
| NEXGEL, Inc. | 4.78 Million USD | -1705.408% |
| OraSure Technologies, Inc. | 52.17 Million USD | -65.717% |
| Pro-Dex, Inc. | 23.34 Million USD | -270.394% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -425.791% |
| Predictive Oncology Inc. | 6.14 Million USD | -1306.906% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -1163.166% |
| QuidelOrtho Corporation | 3.55 Billion USD | 97.569% |
| Repligen Corporation | 853.2 Million USD | 89.866% |
| Sanara MedTech Inc. | 29.28 Million USD | -195.259% |
| STAAR Surgical Company | 102.73 Million USD | 15.843% |
| Sharps Technology, Inc. | 3.85 Million USD | -2142.838% |
| Utah Medical Products, Inc. | 7.14 Million USD | -1110.091% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 97.879% |
| Jin Medical International Ltd. | 8.92 Million USD | -868.822% |